Alliance Pharmaceuticals

UK - WiltshirePharmaceutical1 H-1B visas (FY2023)

Focus: Alliance Pharmaceuticals is a UK-based specialty pharmaceutical company (201–500 employees) focused on acquisition and licensing of marketed drugs and clinical-stage assets. The company operates primarily in neurology with a diversified pipeline spanning oncology, neurology, and infectious disease.

Neurology

Profile data last refreshed 2h ago · AI intelligence enriched 2w ago

Employees

201-500

Open Jobs

About Alliance Pharmaceuticals

AI assessmentNot Hiring

No open roles listed right now. Follow Alliance Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

3/9 — Basic

Company HealthSolid

Pipeline

Early-stage

50 total

LOE Risk

Protected

No near-term cliffs

Hiring

Stable

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Key Products

IMAGENT

Not specified

LOE Approaching

Alliance's only marketed NDA asset; approaching loss of exclusivity with undisclosed timeline and revenue—flagship product erosion is an immediate career stability risk.

Products & Portfolio (1)

Help build intelligence for Alliance Pharmaceuticals

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Exposure to portfolio-scale clinical development: 30 pipeline programs across Phase 1–3 and Phase 4 with 135+ active trials provides breadth in drug development, regulatory, and clinical operations roles.
Acquisition-and-licensing business model creates recurring opportunities in business development, licensing, and commercialization without the R&D cost burden of discovery—lower operational risk.
Mid-cap structure (201–500 employees) offers access to senior decision-makers and cross-functional visibility rare in larger organizations; Commercial hiring is active (3 open roles) suggesting growth.

Pipeline & Clinical Trials

The RECapp platform

Oesophageal Cancer

N/A

Clinical Trials (1)

NCT07642492REcovery After Cancer Application

N/A

Seroquel

Post-Traumatic Stress Disorder

N/A

Clinical Trials (1)

NCT01066156Post-Traumatic Stress Disorder (PTSD) and Seroquel

N/A

An enhanced model of hepatitis B testing and linkage to care

Viral Hepatitis B

N/A

Clinical Trials (1)

NCT06403657DEcentralize Testing, Education, and Linkage to Care by Using Electronic Best Practice Advisory for Hepatitis B (DETECT-B)

N/A

Fecal Fat

Exocrine Pancreatic Insuficiency

N/A

Clinical Trials (1)

NCT07335523Determine the Prevalence of Exocrine Pancreatic Insufficiency (EPI) in Pediatric and Adult Participants With Alagille Syndrome After Liver Transplantation

N/A

alpelisib

Lymphangioma

N/A

Clinical Trials (1)

NCT03941782Compassionate Use of BYL 719 Alpelisib

N/A

long-acting depot buprenorphine

Opioid Dependence

N/A

Clinical Trials (1)

NCT06129916Assessing the Acceptability, Feasibility, Effectiveness and Cost-effectiveness of LADB

N/A

caplacizumab

Immune Thrombotic Thrombocytopenia

N/A

Clinical Trials (1)

NCT06358703Impact of Acute ITTP Therapies on Long Term Neurologic and Cognitive Outcomes in ITTP Survivors

N/A

Lithium Carbonate

Bipolar Disorder

N/A

mutation analysis

Colorectal Cancer

N/A

Clinical Trials (1)

NCT00048971Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy

N/A

No intervention. Retrospective observation only.

Chronic Inflammatory Demyelinating Polyneuropathy

N/A

Heart-Smile Training Intensive Introduction Program

Depression

N/A

Clinical Trials (1)

NCT05564533Heart-Smile Training Intensive Introduction Program

N/A

Mindfulness Training for Primary Care

Depression

N/A

Clinical Trials (1)

NCT02972203MINDFUL-PC: Integrating Mindfulness Into the Patient-Centered Medical Home

N/A

Recovery Factors

Fibromyalgia

N/A

Clinical Trials (1)

NCT04381780Treatment of Fibromyalgia With Recovery Factors

N/A

Supportive Care

Breast Cancer

N/A

Clinical Trials (1)

NCT06260332Physical Activity Intervention for the Improvement of Pain in Young, Hispanic Breast Cancer Survivors

N/A

MV-POCT Sub-study

Prostate Cancer

N/A

Clinical Trials (1)

NCT06357416The Man Van Project

N/A

Mathematical modeling to predict response to chemotherapy

Breast Cancer

N/A

Clinical Trials (1)

NCT03983538Mathematical Modeling to Predict Response to Neoadjuvant Chemotherapy in Breast Cancer

N/A

BraveNet Multi-Center Study on Integrative Medicine Treatment Approaches for Pain

Chronic Pain

N/A

Clinical Trials (1)

NCT01186341BraveNet Multi-Center Study on Integrative Medicine Treatment Approaches for Pain

N/A

tSVF by lipoaspiration

Alopecia Areata

N/A

KY LEADS Survivorship Care

Lung Cancer

N/A

cytogenetic analysis

Acute Leukemia

N/A

Clinical Trials (1)

NCT00048958Cytogenetic Studies in Acute Leukemia and Multiple Myeloma

N/A

Neurology Measures in FA Children

Friedreich Ataxia

N/A

Mindfulness Training for Primary Care

Anxiety

N/A

Clinical Trials (1)

NCT03609749Mindful Self-Regulation fMRI Study (MindfulPCfMRI)

N/A

DASH-FP

Type 2 Diabetes

N/A

Clinical Trials (1)

NCT05589467Effects of Potatoes on Blood Pressure in Persons With and Without Type 2 Diabetes Who Follow the DASH Diet for 6 Weeks

N/A

Quality of Life Ted Talks

Colon Cancer

N/A

Clinical Trials (1)

NCT04713007Improving Quality of Life for Colon Cancer Patients and Their Caregivers

N/A

Early and Longitudinal Assessment of Neurodegeneration in the Brain and Spinal Cord in Friedreich's

Friedreich Ataxia

N/A

Clinical Trials (1)

NCT01776164Early and Longitudinal Assessment of Neurodegeneration in the Brain and Spinal Cord in Friedreich's Ataxia

N/A

polymorphism analysis

Breast Cancer

N/A

Clinical Trials (1)

NCT00968214Study of Tumor and Blood Samples From Postmenopausal Women With Primary Breast Cancer Enrolled on Clinical Trial CAN-NCIC-MA27

N/A

Usual Care

Breast Cancer Stage 0

N/A

Clinical Trials (1)

NCT03766009Increasing Patients' Engagement in Breast Cancer Surgery Decision-Making

N/A

6-Mercaptopurine

Acute Lymphoblastic Leukemia

N/A

Clinical Trials (1)

NCT01324336Comparative Pharmacokinetics of a Compounded 6-mercaptopurine Liquid Formulation Preparation and Tablets

N/A

Text messages

Type 2 Diabetes

N/A

Clinical Trials (1)

NCT05641402Evidence-based Text Messages to Target Diet and Physical Activity

N/A

Conventional radiotherapy schedule

Breast Cancer

N/A

Clinical Trials (1)

NCT00156130Accelerated Radiotherapy Outcomes in Women

N/A

Dietary intervention

Colorectal Cancer

N/A

Clinical Trials (1)

NCT06212817Dietary Fiber Before Colorectal Cancer Surgery

N/A

Teens Taking Charge

Juvenile Idiopathic Arthritis

N/A

Clinical Trials (1)

NCT01011179Internet Self-Management Program With Telephone Support for Adolescents With Arthritis

N/A

PCI with SELUTION SLR DCB

Coronary Artery Disease

N/A

MySafeRx

Opioid Use Disorder

N/A

Clinical Trials (1)

NCT02942199MySafeRx & MedicaSafe Open-Label Buprenorphine Induction and Lapse Evaluation (MyMOBILE)

N/A

immunohistochemistry staining method

Head and Neck Cancer

N/A

Clinical Trials (1)

NCT00042926Diagnostic Trial in Patients Who Are Undergoing Surgery for Early Stage Mouth Cancer

N/A

Point of Care

Cardiovascular Diseases

N/A

functional Near Infrared Spectroscopy

Major Depression

N/A

Clinical Trials (1)

NCT01768052Functional Brain Imaging Study of Response to Repetitive TMS (rTMS) Treatment of Major Depression

N/A

Interviews - Colorectal Cancer Participants

Colorectal Cancer

N/A

Clinical Trials (1)

NCT02217865Patient-Centered Risk Adjusted Surveillance After Curative Resection of Colorectal Cancer

N/A

Childcare Navigator

Obesity, Childhood

N/A

Clinical Trials (1)

NCT05477628Nutrition Recommendation Intervention trialS in Children's Healthcare

N/A

Enhanced Usual Care Group

Hypertension

N/A

Clinical Trials (1)

NCT04010344Addressing Hypertension Care in Africa

N/A

MRI scan

Rectal Cancer

N/A

Clinical Trials (1)

NCT04103372Pre-therapeutic MRI Assessment of Early-Stage Rectal Cancer and Significant Rectal Polyps to Avoid Major Resectional Surgery

N/A

microarray analysis

Leukemia

N/A

Clinical Trials (1)

NCT00898092Genetics Study of Tissue Collected From Patients With Acute Myeloid Leukemia

N/A

Feedback

Chronic Obstructive Pulmonary Disease

N/A

Clinical Trials (1)

NCT02895152Activity Monitor Use in COPD Patients Undergoing Rehabilitation

N/A

Questionnaire Administration

Acute Lymphoblastic Leukemia

N/A

Clinical Trials (1)

NCT05334069Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

N/A

diagnostic laboratory biomarker analysis

Breast Cancer

N/A

Clinical Trials (1)

NCT00898898Studying Tissue Samples From Women With Breast Cancer Who Were Treated on Clinical Trial NCCTG-N9831

N/A

mammography

Breast Cancer

N/A

Clinical Trials (1)

NCT00316836Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole

N/A

T1 mapping

Fabry Disease

N/A

Clinical Trials (1)

NCT04708301Characterisation of Heart Involvement in Fabry Disease With T1 Mapping

N/A

N-Acetylcysteine

Schizophrenia

N/A

Clinical Trials (1)

NCT01232790A Pilot Trial of Acute N-Acetylcysteine Effects on Working Memory and Other Cognitive Functions in Schizophrenia

N/A

flow cytometry

Leukemia

N/A

Clinical Trials (1)

NCT00896701Relationship Between Natural Killer Cells' Ability to Kill Leukemia Cells and the Outcome of Patients With Acute Myeloid Leukemia Previously Treated With Interleukin-2

N/A

Project ECHO

Depression

N/A

Clinical Trials (1)

NCT05646212Integrating Treatment for Mental Disorders in Methadone Clinics in Ukraine

N/A

Interview Prep Quick Facts

Portfolio: 1 approved product, 143 clinical trials

Top TAs: Oncology, Neurology, Infectious Diseases

H-1B (2023): 1 approval

Publications: 2 in PubMed

Portfolio Health

LOE Approaching1 (100%)

1 total products

Therapeutic Area Focus

658 pipeline

140 pipeline

76 pipeline

40 pipeline

25 pipeline

Hiring Trend

Stable

Open Roles

Added

-0

Filled/Removed

Based on last 4 crawl cycles

Visa Sponsorship

Sponsors Work Visas

H-1B Petitions (FY2023)

Approved

Denied

100%

Rate

Source: USCIS H-1B Employer Data Hub

Research Publications(2)

Recent peer-reviewed publications with author affiliations at this company

Clinical Evaluation of Effectiveness and Safety of Combined Use of Dietary Supplements Amberen(®) and Smart B(®) in Women with Climacteric Syndrome in Perimenopause.

Advances in therapy

2024

PMID:38904899

Immunologic control of tumors by in vivo Fc gamma receptor-targeted antigen loading in conjunction with double-stranded RNA-mediated immune modulation.

Alliance Pharmaceuticals

About Alliance Pharmaceuticals

Why Work Here

Key Products

Products & Portfolio (1)

Watch Out For

Pipeline & Clinical Trials

Open Jobs (0)

Hiring Trend

Visa Sponsorship

Research Publications(2)